Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older
Identifying Challenges to Healthy Aging in Persons With HIV Age 50 and Older
Wake Forest University Health Sciences
100 participants
Jun 27, 2023
INTERVENTIONAL
Conditions
Summary
The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency virus (HIV) followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinics (IDSC).
Eligibility
Inclusion Criteria6
- Person living with human immunodeficiency virus (HIV)
- Age ≥50 years
- Followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinic (IDSC)
- Eligible for Ryan White Program
- Able to provide informed consent
- Pre-frail or frail by electronic frailty index (eFI)
Exclusion Criteria2
- Age \<50 years (study designed to characterize frailty in aging persons with HIV)
- Unable to complete the required assessments or questionnaires
Interventions
Clients with identified challenges to successful aging (pre-frail or frail on screening) will be invited to develop an individualized activity plan to increase mobility, strength, and stamina. Plans will combine activities to improve strength (resistance training), balance (balance exercises), and stamina, and establish weekly goals. Resistance bands and pedometers will be provided. Progress will be measured by self-reported adherence to the activity plan at week 2, 4, 8, 12 and 24 (assessed by telephone at weeks 2, 4, 8 and in person at week 12 and 24). Depression questionnaire (PHQ-9), fatigue screen, exhaustion questions, and SF-12, a measure of health-related quality of life, will be administered at baseline, week 12 and 24.
Participants with nutritional needs will have the option of meeting with a nutritionist to develop a personalized nutritional plan with a goal of improving diet quality and optimizing caloric intake. Progress will be measured as above.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05858034